Skip to main content
A WORLDWIDE ALLERGY COMPANY
A WORLDWIDE ALLERGY COMPANY
Find your location
  • Global
    •
  • Australia
    •
  • Austria
    •
  • Belgium
    •
  • Canada
    •
  • Czech republic
    •
  • France
    •
  • Germany
    •
  • Italy
    •
  • Netherlands
    •
  • Middle East
    •
  • New Zealand
    •
  • Nordics
    •
  • Poland
    •
  • Russia
    •
  • Slovakia
    •
  • Spain
    •
  • Switzerland
    •
  • United Kingdom
    •
  • USA
    •
  • ABOUT
    • Our business
    • Global footprint
    • Strategy
      • Board of Directors
      • Executive committee
      • Compliance, Ethics, Transparency
      Governance
    • History
  • IMPACT
    • Corporate responsibility
    • Foundation
  • ALLERGIES
    • About allergies
    • Respiratory allergies
    • Food allergy
    • Veterinary allergies
    • Allergens
  • SOLUTIONS
    • Diagnosis
    • Patient journey
    • Treatment
    • Portfolio
  • SCIENCE
    • Precision medicine
    • Clinical Development
    • Manufacturing
    • Partnering
  • NEWS CENTER
    • Press releases
    • Publications
    • 2023 Company Report
  • CAREERS
    • Our culture
    • Testimonials
    • Explore job opportunities
  • ABOUT
    • Our business
    • Global footprint
    • Strategy
    • Governance
      • Board of Directors
      • Executive committee
      • Compliance, Ethics, Transparency
    • History
  • IMPACT
    • Corporate responsibility
    • Foundation
  • ALLERGIES
    • About allergies
    • Respiratory allergies
    • Food allergy
    • Veterinary allergies
    • Allergens
  • SOLUTIONS
    • Diagnosis
    • Patient journey
    • Treatment
    • Portfolio
  • SCIENCE
    • Precision medicine
    • Clinical Development
    • Manufacturing
    • Partnering
  • NEWS CENTER
    • Press releases
    • Publications
    • 2023 Company Report
  • CAREERS
    • Our culture
    • Testimonials
    • Explore job opportunities
Find your location
  • Global
    •
  • Australia
    •
  • Austria
    •
  • Belgium
    •
  • Canada
    •
  • Czech republic
    •
  • France
    •
  • Germany
    •
  • Italy
    •
  • Netherlands
    •
  • Middle East
    •
  • New Zealand
    •
  • Nordics
    •
  • Poland
    •
  • Russia
    •
  • Slovakia
    •
  • Spain
    •
  • Switzerland
    •
  • United Kingdom
    •
  • USA
    •

Breadcrumb

  2. News center
  3. Press releases
News center

Breadcrumb

  2. News center
  3. Press releases
News center
  • Press releases
  • Publications
  • 2023 Company Report
News center

Press releases

For matters related to Global communications, please contact:

Catherine Kress 

Head of Communications

Email: communications@stallergenesgreer.com

Tel:  +33 (0)1 55 59 26 05

S'inscrire

Parcourir par année

  • 2010
  • 2011
  • 2012
  • 2013
  • 2014
  • 2015
  • 2016
  • 2017
  • 2018
  • 2019
  • 2020
  • 2021
  • 2022
  • 2023
  • 2024
  • 2025

2010-11-02 - Stallergenes accueille favorablement l'entrée d'Ares Life Sciences au sei...

Télécharger

2010-10-14 - Croissance soutenue pour Stallergenes

Télécharger

2010-09-06 - Stallergenes et Shionogi signent un accord de partenariat exclusif concerna...

Télécharger

2010-08-26 - Résultats du 1er semestre 2010

Télécharger

2010-06-28 - Une efficacité persistante démontrée après un an sous Actair® suivi d'une ...

Télécharger

2010-06-21 - Etude clinique Staloral® acariens 300 en Chine : l’efficacité de l'immunot...

Télécharger

2010-05-19 - Résultats positifs de l'étude de phase III d'Oralair® aux Etats-Unis

Télécharger

2010-05-15 - Chiffre d'affaires T1 2010

Télécharger

2010-03-16 - Résultats financiers 2009

Télécharger

2010-01-14 - Forte croissance du chiffre d'affaires au 4ème trimestre : +15%

Télécharger
  • Press releases
  • Publications
  • 2023 Company Report
© 2025 Stallergenes Greer
    |
  • Site Map
    • |
  • terms & conditions
    • |
  • Modern Slavery Act Statement
    • |
  • Contact
  • Cookie Policy
    • |
  • Personal Data Protection Policy

YOU ARE LEAVING THE STALLERGENESGREER.COM WEBSITE

This link will take you to content that may not be appropriate for UK audiences on a website to which our Privacy Policy does not apply. Stallergenes Greer UK has no control over the contents of these sites or resources, and accepts no liability or responsibility for them or for any loss or damage that may arise from your use of them.

Continue

Cookies

Reject and continue

STALLERGENES GREER uses technical cookies essential for the functioning of the site as well as audience measurement cookies. You can accept audience measurement cookies by clicking on “Accept” or reject them by clicking on “Reject and continue”. You can change your mind at any time by clicking on “Cookies Management” and manage your preferences by clicking on “Set your preferences”. For more information, please read our Cookie Policy

Set your preferences

Google Analytics
Track website traffic
Save my preferences
Set your preferences
Accept Save my preferences
Cookies Management